7/16/2024

Esmolol Injection

Products Affected - Description

- Esmolol, Baxter, 10 mg/mL, 10 mL preservative-free vial, 25 count, NDC 10019-0120-01
- Esmolol, Eugia US, 10 mg/mL, 10 mL preservative-free vial, 25 count, NDC 55150-0194-10
- Esmolol, Fresenius Kabi, 10 mg/mL, 10 mL preservative-free vial, 25 count, NDC 63323-0652-10
- Esmolol, Mylan Institutional (Viatris), 10 mg/mL, 10 mL preservative-free vial, 10 count, NDC 67457-0182-10
- Esmolol, WG Critical Care, 10 mg/mL, 250 mL in water premixed bag, 10 count, NDC 44567-0811-10
- Esmolol, WG Critical Care, 20 mg/mL, 100 mL in water premixed bag, 10 count, NDC 44567-0812-10

Reason for the Shortage

- Amneal has esmolol injection available.
- Baxter has esmolol on shortage due to increased demand.
- Eugia did not provide a reason for the shortage.
- Fresenius Kabi did not provide a reason for the shortage.
- Sagent has esmolol injection available.
- Viatris did not provide a reason for the shortage.
- WG Critical Care has esmolol on shortage due to shipping delays.

Available Products

- Brevibloc, Baxter, 10 mg/mL, 10 mL preservative-free vial, 25 count, NDC 10019-0115-01
- Brevibloc, Baxter, 10 mg/mL, 250 mL in sodium chloride premixed bag, 10 count, NDC 10019-0055-61
- Brevibloc, Baxter, 20 mg/mL, 100 mL in sodium chloride premixed bag, 10 count, NDC 10019-0075-87
- Esmolol, Amneal, 10 mg/mL, 250 mL in sodium chloride premixed bag, 10 count, NDC 70121-1716-07
- Esmolol, Amneal, 20 mg/mL, 100 mL in sodium chloride premixed bag, 10 count, NDC 70121-1717-07
- Esmolol, Mylan Institutional (Viatris), 10 mg/mL, 250 mL in sodium chloride premixed bag, 10 count, NDC 67457-0657-25
- Esmolol, Mylan Institutional (Viatris), 20 mg/mL, 100 mL in sodium chloride premixed bag, 10 count, NDC 67457-0658-10
- Esmolol, Sagent, 10 mg/mL, 250 mL in sodium chloride premixed bag, 10 count, NDC 25021-0308-84
- Esmolol, Sagent, 20 mg/mL, 100 mL in sodium chloride premixed bag, 10 count, NDC 25021-0309-82
- Esmolol, WG Critical Care, 10 mg/mL, 250 mL in sodium chloride premixed bag, 10 count, NDC 44567-0450-10
- Esmolol, WG Critical Care, 20 mg/mL, 100 mL in sodium chloride premixed bag, 10 count, NDC 44567-0451-10

Estimated Resupply Dates

- Baxter has esmolol 10 mg/mL 10 mL vials available in limited supply.
- Eugia has esmolol 10 mg/mL 10 mL vials on intermittent back order and the company is releasing product as it becomes available.
- Fresenius Kabi has esmolol 10 mg/mL 10 mL vials on back order and the company cannot estimate a release date.
- Viatris has esmolol 10 mg/mL 10 mL vials on back order and the company estimates a release date of mid- to late-August 2024.
- WG Critical Care has esmolol 10 mg/mL 250 mL premixed bags in water and 20 mg/mL 100 mL premixed bags in water on back order and the company cannot estimate a release date.

Updated

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.